Drug Patents owned by Marius Pharms Llc
1. List of Kyzatrex drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10576089 | MARIUS PHARMS LLC | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
Dec, 2030
(7 years from now) | |
| US10576090 | MARIUS PHARMS LLC | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
Dec, 2030
(7 years from now) | |
Do you want to check out KYZATREX patents from before 2022?
| Exclusivity | Exclusivity Expiration |
|---|---|
| New Product (NP) | Jul 27, 2025 |
Drugs and Companies using TESTOSTERONE UNDECANOATE ingredient
Market Authorisation Date: 27 July, 2022
Treatment: Method of treating testosterone deficiency
Dosage: CAPSULE;ORAL
More Information on Dosage
KYZATREX family patents
12
United States
3
European Union
2
Spain
2
Japan
1
New Zealand
1
Poland
1
China
1
Hong Kong
1
Canada
1
Portugal
1
Taiwan
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic